CD36 and steatosis: Hepatic expression of CD36 is abnormally increased in non-alcoholic fatty liver disease, and a previous study indicated that hepatic CD36 upregulation was significantly associated with insulin resistance, hyperinsulinemia and increased steatosis in patients with NAFLD (22).